Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.QT Imaging Holdings, Inc. (QTI) Q3 2026 Earnings Call Transcript
QT Imaging Reports 75% Third Quarter Revenue Growth and Major Medicare Reimbursement Milestone
QT Imaging Secures First GCC Commercial Order from American Hospital Dubai, Plans Clinical Research Collaboration
QT Imaging Secures Medicare Outpatient Reimbursement for QTscan®, Effective January 2027
QT Imaging to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
QT Imaging to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026
QT Imaging's Breast Acoustic CT™ Scanner Now Available Through National Group Purchasing Agreement with Premier
QT Imaging's Breast Acoustic CT™ Scanner Now Available Through National Group Purchasing Agreement with Premier
QT Imaging Announces CPT® Category III Code for 3D Breast Acoustic Imaging Now Effective
QT Imaging to Ring the Nasdaq Closing Bell on October 2 in Recognition of Breast Cancer Awareness Month
QT Imaging to be Honored at Premier's Annual Supplier Innovation Celebration
QT Imaging Appoints Imaging Industry Veteran Dr. Mark Winkler as Chief Medical Officer
QT Imaging Holdings, Inc. (QTI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript
QT Imaging to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference
QT Imaging Issues Mid-Year 2026 CEO Letter to Shareholders
QT Imaging Holdings, Inc. (QTI) Q2 2026 Earnings Call Transcript
QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale
QT Imaging to Report Second Quarter 2026 Financial Results and Host Conference Call on August 12, 2026
QT Imaging Advances Direct U.S. Commercial Strategy to Accelerate Adoption of its Breast Acoustic CT Scanner with Two Key Hires
QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer